 Shares in Tiziana Life Sciences plc NASDAQ:TLSA, LON:TILS shot up 20 after it announced the US regulator has approved the use of its nasally administered monoclonal antibody to treat a person with secondary progressive multiple sclerosis SPMS. Foralumab will be provided under the Food Drug Administrations individual patient expanded access protocol overseen by researchers at the Brigham and Womens Hospital BWH, Harvard. 